DTP-Haemophilus influenza B-vaccine （Wockhardt）

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTP-Haemophilus influenza B-vaccine （Wockhardt）
Drug Alias NameDiphtheria, acellular Pertussis, Tetanus and Hemophilus influenza bDTaP-Hib combination vaccine
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesWockhardt Bio Ag
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Ltd
Inactive CompaniesN/A
Active IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A